SUP-T1

T-cell lymphoma

Cell Type:
T Cell
Tissue Origin:
blood
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
V O-017 1e6 68% 88% Plasmid (general) 2 µg 100 µl I/II/2b
V T-016 1e6 64% 74% Plasmid (general) 2 µg 100 µl I/II/2b
V U-020 5e6 31% 95% Plasmid (general) 3 µg 100 µl I/II/2b
SF CM-150 6e5 46% 85% Plasmid (general) 0.4 µg 20 µl 4D X-Unit
SF CA-137 6e5 65.8% 69.7% Plasmid (general) 0.4 µg 20 µl 4D X-Unit

Citations

Categories:
Transfection 
Authors:
Piganeau M, Ghezraoui H, De Cian A, Guittat L, Tomishima M, Perrouault L, René O, Katibah GE, Zhang L, Holmes MC, Doyon Y, Concordet JP, Giovannangeli C, Jasin M, Brunet E. 
In:
Genome Res (2013) 23(7): 1182-93 
Categories:
Transfection 
Authors:
Noviello CM, Benichou S, Guatelli JC 
In:
J Virol (2008) 82(3): 1249-58 
Categories:
Transfection 
Authors:
Bourara K, Liegler TJ, Grant RM 
In:
PLoS Pathog (2007) 3(10): 1477-85 
Categories:
Transfection 
Authors:
Noviello CM, Kosakovsky Pond SL, Lewis MJ, Richman DD, Pillai SK, Yang OO, Little SJ, Smith DM, Guatelli JC 
In:
J Virol (2007) 81(9): 4776-86